Elton’s Health Hacks
Do GLP-1 drugs cause cancer or prevent it ? Welcome back to Elton's Health Hacks! In today’s deep dive, we are exploring one of the most unexpected and exciting developments with GLP-1 medications like Ozempic, Wegovy, and Mounjaro for their weight-loss and diabetes applications, but could they actually be our newest weapon against cancer? We break down the staggering new data from major medical studies and explain the cellular biology behind how these drugs might be starving tumors and rewriting our immune system's defensive playbook. What You Will Learn In This Episode: * The Breast Cancer Data: A massive study of over 110,000 women showed those taking GLP-1 drugs had roughly a 30% lower likelihood of developing breast cancer. * Survival Rates: Recent research out of UC San Diego found that colon cancer patients using GLP-1 medications were less than half as likely to die within five years compared to non-users. * Beyond Weight Loss: Studies suggest these medications can directly enhance immune function, specifically boosting natural killer (NK) cells that destroy cancer cells. * Cellular Defense: GLP-1 receptor agonists are known to lower body-wide inflammation and improve metabolic health, which can interrupt pathways that promote cancer growth. * The Fine Print: We discuss the FDA black box warnings regarding thyroid C-cell tumors observed in rodent studies, as well as a potential increased risk of kidney cancer noted in some research. Important Disclaimer: We are researchers and guides, not medical doctors. The research discussed today is primarily observational, meaning it does not yet prove that GLP-1 drugs directly prevent cancer. Always consult your physician before making any medical decisions or starting new treatments.
50 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Elton’s Health Hacks-Community!